°­ÀǽÅûRegistration

ÆÐÅ°Áö°­ÀÇ

Ȩhome > °­ÀǽÅû > ÆÐÅ°Áö°­ÀÇ

°­Á¼Ұ³ ¹× ¸ñÂ÷
  • ÆÐÅ°ÁöÀ̹ÌÁö

    °­Á¸í
    ½ÇÀüÀÓ»ó¾àÇÐ 3 [³»ºÐºñ Áúȯ/½ÉÇ÷°ü Áúȯ]
    °­Á¼Ұ³
    º» °­ÀǸ¦ ¼ö°­ÇÏ´Â Àϼ± ¾à»ç´ÔµéÀº ¼±ÁøÀÓ»ó¾àÇп¡ ´ëÇÑ °³³ä°ú Áö½ÄÀ» ȹµæÇÏ¿©
    ¾à¹« ÇöÀå¿¡¼­ ȯÀÚ¿¡ ´ëÇÑ Ä¡·á¸¦ °­È­ÇÏ°í À̸¦ ½ÇÁ¦ÀûÀ¸·Î Àû¿ëÇÔÀ¸·Î½á
    ¾à±¹ °æ¿µ°ú Á÷´ÉÀÇ Àü¹®¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

    °¢ °úÁ¤Àº Áúȯº° º´Å»ý¸®, ÀÓ»óÁõ»ó, ¾à¹°Ä¡·á¸¦ Áß½ÉÀ¸·Î °­ÀÇ°¡ ÁøÇàµÇ¸ç,
    º» °­ÀÇ [ÀÓ»ó¾àÇÐ Session 3 ³»ºÐºñ/½ÉÇ÷°ü Áúȯ]Àº Áúȯº° º» °­Á·Π´ç´¢, °©»ó¼± Áúȯ, ºÎÀΰú Áúȯ, °íÇ÷¾Ð, ³úÁ¹Áõ µîÀÇ ¼¼ºÎÀûÀÎ Áö½ÄÀ» ½ÀµæÇÒ ¼ö ÀÖ´Â °­ÁÂÀÔ´Ï´Ù.

    ¹Ì±¹ ¾àÇдëÇп¡¼­ ÆʵðÇÐÀ§¸¦ ÃëµæÇÏ°í ÇöÀç ±¹³» Á¦¾à»ç, º´¿ø, ¾à±¹, ´ëÇп¡¼­
    ¿Õ¼ºÇÏ°Ô È°µ¿ ÁßÀÎ ±³¼öÁøÀÌ ÁÖÃàÀÌ µÇ¾î Áö±Ý±îÁö ¹è¿ì°í ÀÍÇû´ø ¼±ÁøÀÓ»ó¾àÇÐ Áö½Ä°ú
    ½ÇÁ¦ ±Ù¹«ÇöÀå¿¡¼­ üµæÇÑ ½ÇÀü °æÇèÀ» ¹ÙÅÁÀ¸·Î Àϼ± ¾à»ç´Ôµé¿¡°Ô °­ÀǸ¦ Á¦°ø ÇÕ´Ï´Ù.

    °¢ °úÁ¤Àº Áúȯº° º´Å»ý¸®, ÀÓ»óÁõ»ó, ¾à¹°Ä¡·á¸¦ Áß½ÉÀ¸·Î °­ÀÇ°¡ ÁøÇàµÇ¸ç,
    º» °­ÀÇ [Session 3 ³»ºÐºñ/½ÉÇ÷°ü Áúȯ]Àº Áúȯº° º» °­Á·Π´ç´¢, °©»ó¼± Áúȯ, ºÎÀΰú Áúȯ, °íÇ÷¾Ð, ³úÁ¹Áõ µîÀÇ ¼¼ºÎÀûÀÎ Áö½ÄÀ» ½ÀµæÇÒ ¼ö ÀÖ´Â °­ÁÂÀÔ´Ï´Ù.

    [°­»ç¼Ò°³]

    ¼­Èñ³² Pharm.D.

    - °æÈñ´ëÇб³ ¾àÇаú Á¹¾÷
    - University of Florida, Pharm.D.
    - Çö) ´ëÇÐ °­ÀÇ
    - Çö) °­ºÏ»ï¼ºº´¿ø ¾àÁ¦°ú

    À¯±â¿¬ Pharm.D.

    - µ¿´ö¿©ÀÚ´ëÇб³ ¾àÇаú Á¹¾÷
    - ¼÷¸í¿©ÀÚ´ëÇб³ ÀÓ»ó¾àÇдëÇпø ¼®»ç
    - U. Of Florida, Pharm.D.
    - Çö) µ¿´ö¿©ÀÚ´ëÇб³ ¾àÇаú ±³¼ö

    ±èÀº¿µ Pharm.D.

    - ÀÌÈ­¿©ÀÚ´ëÇб³ ¾àÇаú
    - ÀÌÈ­¿©ÀÚ´ëÇб³ ´ëÇпø ¼®»ç ¹× ¹Ú»ç ¼ö·á
    - University of Florida, Pharm.D.
    - ¹Ì±¹ ¾à¹°Ä¡·áÇÐ Àü¹®¾à»ç (BCPS)
    - Àü) ¼­¿ï»ï¼ºº´¿ø ¾àÁ¦ºÎ
    - Çö) Ãæ³²´ëÇб³ ¾àÇаú ±³¼ö

    ±èÁ¾À± Pharm.D.

    - °æÈñ´ëÇб³ ¾àÇаú
    - °æÈñ´ëÇб³ ´ëÇпø ¼®»ç
    - University of Florida, Pharm.D.
    - Àü) ³ì½ÊÀÚ °³¹ßÆÀ
    - Àü) ¼­¿ï¾Æ»êº´¿ø ¾àÁ¦ÆÀ
    - Çö) »ç°ú³ª¹« Àӻ󿬱¸¼Ò ¿¬±¸¿ø
    °­Á ±â°£/°¡°Ý
    50 / 250,000¿ø
    ±³Àçºñ
    15,000¿ø
    °­Á¸ñÂ÷
    1) ´ç´¢ (2)
    2) °©»ó¼± Áúȯ
    3) Medication Use in Pregnancy & Lactation - 1.Acute
    4) 2. Chronic & Contraception
    5) Menopause
    6) Menstruation Related DZ / Osteoporosis
    7) ½ÉÀåÀÇ ±¸Á¶
    8) »ý¸®ÇÐ, º´Å»ý¸®ÇÐ
    9) ³»ÇǼ¼Æ÷ ±â´É Àå¾Ö & Ç÷°ü Áúȯ
    10) °íÁöÇ÷Áõ
    11) Hypertension
    12) Heart Failure
    13) Rhythm disorder
    14) Stroke / TIA
    15) ½ÉºÎÁ¤¸ÆÇ÷ÀüÁõ / Æó»öÁõ / Ç×ÀÀ°í Ä¡·á
    16) Managing complications of antithrombotic therapy..
    17) ±Þ¼º°ü»óµ¿¸ÆÁõÈıº
    18) °ü»óµ¿¸Æ ¿ìȸ·ÎÀ̽ļú
No °­ÁÂ¸í ´ã´ç±³¼ö ¼ö°­±â°£ ¼ö°­·á ±³Àçºñ °­ÀÇ»ùÇÄ ¼ö°­½Åû
1 »ì¾ÆÀÖ´Â º¹¾àÁöµµ 2 ±è¼ºÃ¶ 34°­
(60ÀÏ)
200,000¿ø50,000¿ø  ¼ö°­
2 °Ç°­±â´É½ÄÇ°°ú Áúº´º° ¿µ¾ç¿ä¹ý ¹Ú¿µ¼ø 74°­
(60ÀÏ)
200,000¿ø0¿ø ¼ö°­
3 À£ºùÄɾÅä¾î Ư°­ ¹Ú¿µ¼ø 1°­
(10ÀÏ)
10,000¿ø0¿ø  ¼ö°­
4 ´Ùºóµµ Áúȯ Ư°­ ¹Ú¿µ¼ø 18°­
(30ÀÏ)
100,000¿ø0¿ø  ¼ö°­
5 ÀϹÝÀǾàÇ° ¿ÏÀüÁ¤º¹ ¹Ú±Ôµ¿ 40°­
(60ÀÏ)
240,000¿ø7,000¿ø  ¼ö°­
6 ½ÇÀüÀÓ»ó¾àÇÐ 1 [ÀÓ»ó¾àÇÐ ±âÃÊ] ¹Ì±¹ Pharm.D. 16°­
(30ÀÏ)
200,000¿ø15,000¿ø  ¼ö°­
7 ½ÇÀüÀÓ»ó¾àÇÐ 2 [È£Èí±â/ÇǺÎ/¾È°ú Áúȯ] ¹Ì±¹ Pharm.D. 15°­
(30ÀÏ)
200,000¿ø15,000¿ø  ¼ö°­
8 ½ÇÀüÀÓ»ó¾àÇÐ 3 [³»ºÐºñ Áúȯ/½ÉÇ÷°ü Áúȯ] ¹Ì±¹ Pharm.D. 18°­
(50ÀÏ)
250,000¿ø15,000¿ø  ¼ö°­
9 ½ÇÀüÀÓ»ó¾àÇÐ 4 [¼ÒÈ­±â Áúȯ/½ÅÀå Áúȯ] ¹Ì±¹ Pharm.D. 19°­
(50ÀÏ)
250,000¿ø10,000¿ø  ¼ö°­
10 ½ÇÀüÀÓ»ó¾àÇÐ 5 [½Å°æÁúȯ/Á¤½Å Áúȯ/¸é¿ª Áúȯ] ¹Ì±¹ Pharm.D. 15°­
(30ÀÏ)
200,000¿ø10,000¿ø  ¼ö°­
11 ÇÁ¸®¹Ì¾ö ¸â¹ö½± ÆÊ³Ý °­»çÁø 0°­
(365ÀÏ)
800,000¿ø0¿ø  ¼ö°­
12 »ì¾ÆÀÖ´Â º¹¾àÁöµµ 1 ±è¼ºÃ¶ 23°­
(60ÀÏ)
250,000¿ø50,000¿ø  ¼ö°­
13 Á¾ÀÌ ÇÑÀåÀ» À§ÇÑ °­ÀÇ ¹Ú¿µ¼ø 17°­
(60ÀÏ)
300,000¿ø0¿ø ¼ö°­
14 Çѹ氭Á ¹Ú¿µ¼ø 67°­
(60ÀÏ)
200,000¿ø50,000¿ø ¼ö°­

¸ð¹ÙÀϹöÀü